EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and Characterization of a Phenyl(trifluoro-methyl)-pyrimidine Positive Allosteric Modulator of the Secretin Receptor

Kaleeckal G Harikumar iD, Daniela G Dengler, Leire Borrega Roman, Robert Ardecky, Eduard A Sergienko, Laurence J Miller iD

Membranes · 21.07.2026 · 16 (7) · 249

DOI: 10.3390/membranes16070249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Membranes, online erschienen am 21.07.2026. Verfasst von Kaleeckal G Harikumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, AZ 85259, USA. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institute of Heart, Lung, and Blood of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G protein-coupled receptors (GPCRs) are among the most common drug targets, with numerous agonists and antagonists approved for clinical use. More recently, it has been appreciated that drugs can also modulate the action of natural agonists of these receptors, thus providing unique clinical advantages. Here, we describe the identification and characterization of a small molecule positive allosteric modulator (PAM) of secretin action at the class B G protein-coupled secretin receptor. This phenyl(trifluoromethyl)-pyrimidine can occupy the secretin receptor without stimulating its internalization, yet priming it to enhance both the potency and efficacy of the action of natural secretin. This is also shown to exhibit its effects on cells expressing low numbers of these receptors, without enhancing the effects of other structurally related hormones acting at other class B GPCRs. The mechanism responsible for this PAM effect is the slowing of the off-rate of receptor-bound secretin. This compound can serve as a lead to the development of other drugs that enhance the action of natural endogenous secretin and can be utilized to explore the potential therapeutic utility of such compounds.

Schlagwörter

Stichwörter der Autor:innen

class B GPCRpositive allosteric modulatorsecretin receptor

Autor:innen und Institutionen

  • Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, AZ 85259, USA.
  • Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.

ORCID-Profile: Kaleeckal G Harikumar, Laurence J Miller

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institute of Heart, Lung, and Blood of the National Institutes of Health

Zitieren

APA

Harikumar, K. G., Dengler, D. G., Borrega Roman, L., Ardecky, R., Sergienko, E. A., & Miller, L. J. (2026). Identification and Characterization of a Phenyl(trifluoro-methyl)-pyrimidine Positive Allosteric Modulator of the Secretin Receptor. Membranes, 16(7), 249. https://doi.org/10.3390/membranes16070249

Vancouver

Harikumar KG, Dengler DG, Borrega Roman L, Ardecky R, Sergienko EA, Miller LJ. Identification and Characterization of a Phenyl(trifluoro-methyl)-pyrimidine Positive Allosteric Modulator of the Secretin Receptor. Membranes. 2026;16(7):249. doi:10.3390/membranes16070249

BibTeX
@article{Harikumar2026,
  author = {Harikumar, Kaleeckal G and Dengler, Daniela G and Borrega Roman, Leire and Ardecky, Robert and Sergienko, Eduard A and Miller, Laurence J},
  title = {Identification and Characterization of a Phenyl(trifluoro-methyl)-pyrimidine Positive Allosteric Modulator of the Secretin Receptor},
  journal = {Membranes},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {249},
  doi = {10.3390/membranes16070249}
}
Kostenlos starten →